Atea Pharmaceuticals, Inc.
AVIR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$168 | -$136 | -$116 | $121 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | -$49 | $0 | -$29 |
| Stock-Based Comp. | $52 | $49 | $47 | $40 |
| Change in WC | -$7 | $16 | -$47 | -$248 |
| Other Non-Cash | -$12 | $33 | -$5 | $29 |
| Operating Cash Flow | -$135 | -$85 | -$121 | -$87 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$2 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$461 | -$562 | -$545 | $0 |
| Inv. Sales/Matur. | $517 | $603 | $92 | $0 |
| Other Inv. Act. | $0 | $0 | -$0 | $0 |
| Investing Cash Flow | $56 | $40 | -$455 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $1 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $0 | $0 | $0 | $1 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$79 | -$45 | -$576 | -$86 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $144 | $189 | $765 | $850 |
| End Cash | $65 | $144 | $189 | $765 |
| Free Cash Flow | -$135 | -$85 | -$123 | -$87 |